News Medical on MSN3d
Using CRISPR to remove extra chromosomes in Down syndrome
Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...
Harvard Medical School1d
Creating the World’s First CRISPR Medicine, for Sickle Cell Disease
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...
AZoLifeSciences on MSN1d
Using CRISPR-Cas9 Gene Editing for Chromosomal Rescue in Down Syndrome
Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...
NanoCas, a smaller version of CRISPR tested with a single AAV, delivers on-target results
Mammoth Biosciences researchers have developed NanoCas, an ultracompact CRISPR nuclease, demonstrating its ability to perform ...
Yahoo Finance1d
CRISPR Therapeutics AG (CRSP)
For its fourth quarter of 2024, CRISPR booked revenue of just under $36 million. On the bottom line, CRISPR flipped to a generally accepted accounting principles (GAAP) loss of $37 million ($0.44 ...
the-tartan4d
NanoCas helps to unlock Mini-CRISPR, first march toward miniature gene editing
By Balambal Suryanarayanan CRISPR-Cas9 is a repurposed gene editing tool that allows scientists to cut, replace, and insert pieces of DNA in precise regions along the strand. Courtesy of NIH Image ...